Issued Patents All Time
Showing 1–25 of 78 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12319703 | Macrocyclic fused pyrazoles as Mcl-1 inhibitors | Guozhi Tang, Dongbo Li, Liugen Li, Xianchan Zha, Wenming Chen +1 more | 2025-06-03 |
| 12145944 | Imidazopyrimidines as EED inhibitors and the use thereof | Rohan Rej, Changwei Wang, Mi Wang, Jianfeng Lu, Chao-Yie Yang +2 more | 2024-11-19 |
| 12012467 | Small molecule DCN1 inhibitors and therapeutic methods using the same | Haibin Zhou, Jianfeng Lu, Liu Liu, Yi Sun, Denzil Bernard | 2024-06-18 |
| 11944614 | Imidazo[4,5-c]pyridine compounds as LSD-1 inhibitors | Rohan Rej | 2024-04-02 |
| 11718613 | N-(phenylsulfonyl)benzamides and related compounds as Bcl-2 inhibitors | Jianyong Chen | 2023-08-08 |
| 11691989 | Macrocyclic indoles as Mcl-1 inhibitors | Hao Chen, Wenming Chen, Chao Li, Dongbo Li, Yu Jing +3 more | 2023-07-04 |
| 11548899 | Fused 1,4-oxazepines and related analogs as BET bromodomain inhibitors | Bing Zhou, Yang Hu, Chao-Yie Yang, Chong Qin | 2023-01-10 |
| 11498928 | Macrocyclic spiroethers as Mcl-1 inhibitors | Jianyong Chen, Yunlong Zhou, Guozhi Tang, Chengzhe Wu, Leilei Zhao +6 more | 2022-11-15 |
| 11466028 | Fused 1,4-oxazepines as BET protein degraders | Yang Hu, Chong Qin, Fuming Xu, Jiantao Hu, Bing Zhou +4 more | 2022-10-11 |
| 11267822 | BET bromodomain protein degraders with cleavable linkers | Weiguo Xiang, Fuming Xu, Longchuan Bai, Ester Fernandez-Salas, Donna McEachern | 2022-03-08 |
| 11192898 | MDM2 protein degraders | Yangbing Li, Jiuling Yang, Angelo Aguilar, Bing Zhou, Jiantao Hu +3 more | 2021-12-07 |
| 11168082 | Pyrrolo[2,3-C]pyridines and related analogs as LSD-1 inhibitors | Dengyou Zhang, Canhui Zheng, Zhuo Chen, Liu Liu, Liyue Huang +1 more | 2021-11-09 |
| 11110090 | Aminopyrimidines as ALK inhibitors | Jianyong Chen | 2021-09-07 |
| 11046709 | Fused 1,4-diazepines as BET bromodomain inhibitors | Jiantao Hu, Fuming Xu | 2021-06-29 |
| 11046703 | Small molecule MDM2 protein degraders | Angelo Aguilar, Yangbing Li, Jiuling Yang, Donna McEachern | 2021-06-29 |
| 11045448 | Piperidines as covalent menin inhibitors | Angelo Aguilar, Shilin Xu, Liyue Huang, Jeanne Stuckey, Tianfeng Xu | 2021-06-29 |
| 10975093 | Fused 1,4-diazepines as BET protein degraders | Yang Hu, Chong Qin, Fuming Xu, Jiantao Hu, Weiguo Xiang +1 more | 2021-04-13 |
| 10899738 | Piperidines as menin inhibitors | Angelo Aguilar, Ke Zheng, Shilin Xu, Tianfeng Xu, Denzil Bernard +1 more | 2021-01-26 |
| 10829488 | N-(phenylsulfonyl)benzamides and related compounds as bcl-2 inhibitors | Jianyong Chen | 2020-11-10 |
| 10781208 | 5,6-dihydro-11H-indolo[2,3-B]quinolin-11-ones as alk inhibitors | Jianyong Chen, Liu Liu, Xuyuan Dong, Chao-Yie Yang, Donna McEachern | 2020-09-22 |
| 10759808 | Monofunctional intermediates for ligand-dependent target protein degradation | Yangbing Li, Angelo Aguilar, Bing Zhou, Jiantao Hu, Fuming Xu +8 more | 2020-09-01 |
| 10709705 | Aminopyrimidines as ALK inhibitors | Jianyong Chen | 2020-07-14 |
| 10633386 | BET protein degraders | Bing Zhou, Fuming Xu, Jiantao Hu, Longchuan Bai, Chao-Yie Yang | 2020-04-28 |
| 10500194 | Covalent small molecule DCN1 inhibitors and therapeutic methods using the same | Haibin Zhou, Jianfeng Lu, Liu Liu, Jeanne Stuckey, Liangyou Rui +1 more | 2019-12-10 |
| 10391175 | BET bromodomain inhibitors and therapeutic methods using the same | Xu Ran, Yujun Zhao, Chao-Yie Yang, Liu Liu, Longchuan Bai +10 more | 2019-08-27 |